January 17, 2018 | Jennifer Mattson
In the summer of 2015, Mollie Warner was living a happy, active life in Rancho Cucamonga, California, with her husband. She worked out regularly at the gym, lifted weights and was even taking a kickboxing class when she started feeling fatigued.
January 30, 2018 | City of Hope
As an affiliate of City of Hope, TGen will use its genomics expertise to chart a path to greater precision in CAR T therapies for cancer patients.
November 9, 2017 | Abe Rosenberg
The exploding field of cancer genomics is enabling that kind of prediction for a growing number of inherited cancers, like identifying one of the many genes beyond BRCA1 and BRCA2 gene mutations linked to breast cancer.
October 16, 2017 | City of Hope
TGen-Riddell partnership results could help future studies lead to advanced methods of injury and disease detection
July 11, 2017 | Denise Heady
A collaboration with The Jackson Laboratory expands access to leading-edge research capabilities to find new treatments for life-threatening diseases.
December 1, 2016 | City of Hope
In this Q and A, Steven T. Rosen, M.D., provost and chief scientific officer for City of Hope, answers questions about the importance of precision of medicine in the fight against cancer and how the City of Hope and TGen alliance will advance research and treatment using this approach.
November 30, 2016 | City of Hope
City of Hope is joining forces with the Translational Genomics Research Institute (TGen) to accelerate the speed with which scientists and medical staff can convert research discoveries into cures for patients.
November 11, 2015 | Cary A. Presant, M.D.
City of Hope's Cary A. Presant, M.D., likes what he sees when he looks back at treatment advances in breast cancer during the past year. A renowned hematologist and medical oncologist, Presant gives his take on recent changes in screening recommendations, chemotherapy regimens and preventative hormonal therapy.
June 15, 2015 | Sara Lewis
Russell Rockne joins Beckman Research Institute of City of Hope to build the new Division of Mathematical Oncology. Many oncologists, not to mention their patients, might think that there's no place for mathematical analysis in the treatment of cancer.